Search
for
Sort by
Research 361–390 of 994
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Menstrual Irregularity in Women with Acromegaly
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Safety of testosterone use in women
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Hormonal treatment of acne vulgaris: an update
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Androgens in women
- Gender-Affirming Hormone Therapy for Transgender Females
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Hairless is a nuclear receptor corepressor essential for skin function
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Endocrine evaluation of hirsutism
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Women's midlife health Reframing menopause
- Obesity and the Polycystic Ovary Syndrome
- Androgen antagonists in androgen target tissues
- Hormonal therapies for acne